Giuliana Grossi

In this interview, Dr. Edigin speaks about his longitudinal trend analysis that showed a decrease in SLE flare hospitalizations over the last 20 years.

The risk of adverse outcomes increased the most in pregnancies with antirheumatic treatment, especially those treated with biologic disease modifying antirheumatic drugs (bDMARDs), when compared with controls.

The study examines the impact of antirheumatic treatment on pregnancy outcomes in women with psoriatic arthritis.

During this video interview, Dr. Jay Mehta talks about his approach to explaining such complex medical conditions and treatments to his pediatric patients and their families.

Dr. Mehta talks about rheumatologic testing, joint examinations, and the great relationships he gets to develop with his patients.

Dr. Mehta highlights some of the challenges that come with treating pediatric rheumatology patients and how he handles them.

In this video interview, Dr. Jay Mehta discusses his presentation on pediatric rheumatology for the American Association of Pediatrics Conference.

The 2 studies focused on upadacitinib treatment for one group of patients with ankylosing spondylitis and another group of patients with non-radiographic axial spondyloarthritis.

Looking specifically at patients who have been treated with biologic disease-modifying anti-rheumatic drugs, this study examines the risk of new or recurrent cancer.

Results show how patients with psoriatic arthritis prioritize their decisions when choosing medication.

Investigators analyze the differences between SARS-CoV-2 testing and risk of infection.

High levels of sedentary activity and low levels of physical activity found in patients with axSpA

Utilizing CIH treatment is effective on its own or in combination with opioid treatment for lower costs.